Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi  Momodou Jobe; Charles Anwuzia-Iwegbu; Ama Banful, Emma Bosier; Mubeen Iqbal; Kelly Jones; Suzanne J Lecutier; Kasimir Lepper; Matt Redmond; Andrew Ross-Parker; Emily Ward; Paul Wernham; Eleanor M Whidden; Kevin M Tyler; Dietmar Steverding PAGE: 946-950 | DOI: 10.1590/S0074-02762012000700018

In vitro and in vivo experimental models for drug screening and development for Chagas disease Alvaro José Romanha; Solange Lisboa de Castro; Maria de Nazaré Correia Soeiro; Joseli Lannes-Vieira; Isabela Ribeiro; André Talvani; Bernadette Bourdin; Bethania Blum; Bianca Olivieri; Carlos Zani; Carmenza Spadafora; Egler Chiari; Eric Chatelain; Gabriela Chaves; José Eduardo Calzada; Juan Manuel Bustamante; Lucio H Freitas-Junior; Luz I Romero; Maria Terezinha Bahia; Michel Lotrowska; Milena Soares; Sonia Gumes Andrade, Tanya Armstrong; Wim Degrave; Zilton de Araújo Andrade PAGE: 233-238 | DOI: 10.1590/S0074-02762010000200022

New approaches in antimalarial drug discovery and development - A Review Anna Caroline C Aguiar; Eliana MM da Rocha; Nicolli B de Souza; Tanos CC França; Antoniana U Krettli PAGE: 831-845 | DOI: 10.1590/S0074-02762012000700001

Achievement of constitutive fluorescent pLEXSY-egfp Leishmania braziliensis and its application as an alternative method for drug screening in vitro Matheus Silva e Bastos, Luciana Ângelo de Souza, Thiago Souza Onofre, Abelardo Silva-Júnior, Márcia Rogéria de Almeida, Gustavo Costa Bressan, Juliana Lopes Rangel Fietto PAGE: 155-159 | DOI: 10.1590/0074-02760160237

Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites Cleyson Mathias Morais Delvoss, Alexandre Haruo Inoue, Rosiane Valeriano da Silva, Stênio Perdigão Fragoso3, Iriane Eger DOI: 10.1590/0074-02760230223